Carnegie acted as sole global co-ordinator and sole bookrunner in the initial public offering of Calliditas on Nasdaq Stockholm. Calliditas is a specialty pharmaceutical company based in Stockholm, Sweden, focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications in which Calliditas can partially or completely participate in the commercialization efforts. June 2018.
Healthcare
Initial public offering of Calliditas Therapeutics AB (SE) on Nasdaq Stockholm — SEK 747 million
June 2018